Arax Advisory Partners’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.09K Sell
127
-46
-27% -$1.63K ﹤0.01% 2881
2025
Q4
$6.23K Buy
173
+165
+2,063% +$6.06K ﹤0.01% 2731
2025
Q3
$251 Sell
8
-17
-68% -$610 ﹤0.01% 3431
2025
Q2
$1.06K Buy
+25
New +$1.04K ﹤0.01% 2755

Other funds holding VCEL

Arax Advisory Partners's VCEL Position: Q1 2026 in Review

Arax Advisory Partners reduced its Vericel Corp (VCEL) stake by 27% in Q1 2026, selling an estimated $1.63K and leaving 127 shares worth $4.09K. The position accounts for ﹤0.01% of the portfolio, ranked #2881.

Arax Advisory Partners first reported a position in VCEL in Q2 2025 and has held it in 4 quarters since. The position peaked at $6.23K in Q4 2025. 279 funds tracked by Wall St. Rank hold VCEL as of Q1 2026.

  • Arax Advisory Partners held 127 shares of Vericel Corp worth $4.09K as of Q1 2026.
  • Arax Advisory Partners sold 46 Vericel Corp shares in Q1 2026, an estimated $1.63K.
  • Vericel Corp made up ﹤0.01% of Arax Advisory Partners's portfolio in Q1 2026, its #2881 holding.
  • Arax Advisory Partners first reported a position in Vericel Corp in Q2 2025 and has held it in 4 quarters since.
  • Arax Advisory Partners's Vericel Corp position peaked at $6.23K in Q4 2025.
  • 279 funds tracked by Wall St. Rank held Vericel Corp as of Q1 2026.

Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.